Home/News/News details

New Market Analysis: Prostate Biopsy Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2022

May 22, 2017

New Market Analysis: Prostate Biopsy Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Prostate biopsy is a medical procedure by which tissue samples are removed from man's prostate gland with the help of hollow needles for diagnosis of cancer.

In ultrasound-guided prostate biopsy, the procedure is done transrectally through the urethra or through perineum. Transperineal template-guided mapping biopsy (TTMB) or   template prostate mapping (TPM) is done which have high rates of detection of prostate cancer. In this process, around 50 to 60 samples are taken from the prostate through the outer skin between scrotum and rectum. The samples and the entire prostate gland then are thoroughly mapped by a 5 mm template under spinal or general anesthesia. MRI guided targeted biopsy is done when prostate cancer is not visible on ultrasound due to poor resolution of soft tissues. MRI guided biopsy is done by direct “in-bore” method, in which the biopsy is done directly inside the MRI tube or fusion method, in which the MRI images are fused with real time ultra sound.

Artemis-Targeted Prostate Biopsy Device- It captures 3D images, automatic recording of all sample sites, does prostate mapping by needle navigation and tracking, semi automatically computes gland volume and boundaries,

Latest prostate biopsy needles by Care Fusion:

  • 4 bevel tip which is up to 54% sharper than normal needle tips.
  • Needle tip up to 85% straighter than standard tips
  • Ergonomic design

2 notch sizes- 10 mm or 20 mm

  • Echogenic markings on canula for correct placement
  • Luer fitting on device
  • Available with coaxial introducer

Navigo™ is another FDA approved prostate biopsy system which uses high resolution 3D technology. The Navigo™ workstation records 3D TRUS prostate biopsy and generates a detailed report. UroNav from Invivo is a Transrectal ultrasound-guided prostate biopsy (TRUS) is also a type of fusion biopsy procedure. It merges electromagnetic tracking and navigation with computer, real-time imaging interface and mobile workstation.

Download Free Sample Report @ https://www.qyresearchgroups.com/request-sample/350999

 

footer pattern

All Copyrights reserve worldhealthcarenews.biz 2017.